ALBO
Albireo Pharma, Inc. Common Stock
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
42 hedge funds and large institutions have $47.8M invested in Albireo Pharma, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
42
Holders Change
+42
Holders Change %
–
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
42
Increased
–
Reduced
–
Closed
–
Calls
$1.46M
Puts
$1.16M
Net Calls
+$304K
Net Calls Change
+$304K
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$11.2M |
| 2 |
JRJ
2
Jeffrey R. Jay
|
$7.75M |
| 3 |
VM
3
VHCP Management
New York
|
$6.05M |
| 4 |
AWMDMG
4
Austin W. Marxe & David M. Greenhouse
New York
|
$4.64M |
| 5 |
5
William Blair & Company
Chicago,
Illinois
|
$3.21M |
Top Sellers
No sellers this quarter
